<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Opaleye Management Inc. — 13F quarterly changes | PlainFundData</title>
    <link>https://plainfunddata.com/fund/opaleye-management-inc</link>
    <description>Every reported quarter of 13F position changes for Opaleye Management Inc., newest first -- real filing data, no fabricated history.</description>
    <language>en-us</language>
    <atom:link href="https://plainfunddata.com/feed/fund/opaleye-management-inc.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>Opaleye Management Inc.: 2024-06-30 13F changes -- 52 sold</title>
      <link>https://plainfunddata.com/fund/opaleye-management-inc</link>
      <guid isPermaLink="false">https://plainfunddata.com/feed/fund/opaleye-management-inc.xml#2024-06-30</guid>
      <pubDate>Sun, 30 Jun 2024 00:00:00 GMT</pubDate>
      <description>Opaleye Management Inc.'s reported 13F position changes for the quarter ending 2024-06-30: 52 sold. Largest moves by dollar value: OCULAR THERAPEUTIX INC (sold, $60,543,556); HARROW INC (sold, $51,869,538); TG THERAPEUTICS INC (sold, $34,678,800).</description>
    </item>
  </channel>
</rss>